| Literature DB >> 35831982 |
Karol Ochocki1, Tomasz Stołtny1, Alina Ostałowska2, Marta Wróbel3, Dominika Rokicka3, Jarosław Pasek4, Sławomir Kasperczyk2, Krzysztof Strojek3, Bogdan Koczy1.
Abstract
BACKGROUND Oxidative stress is a disruption of the pro-oxidative-antioxidant balance, caused by excessive production or ineffective removal of reactive oxygen species. MATERIAL AND METHODS The study included 42 male patients aged 38 to 69 years. The first group consisted of 21 men with osteoarthritis after primary hip arthroplasty using the Smith & Nephew Birmingham Hip Resurfacing implant. The second group included 21 men after hip arthroplasty using the femoral neck SPIRON K-implant. In both groups, concentrations of ions, the antioxidant system in the blood, and parameters of oxidative stress were evaluated twice. Clinical assessment using the Western Ontario and McMaster Universities Osteoarthritis Index, Harris Hip Score, and Short Form (12) Health Survey (SF-12) scales was performed. RESULTS Concentrations of metal ions in the blood and the level of oxidative stress were significantly higher in the resurfacing group than in the femoral neck arthroplasty group. The response of the antioxidant system was significantly greater in the femoral neck arthroplasty group. During clinical evaluation, groups did not show significant differences, with the exception of greater shortening of the operated limb and a lower score in the mental-sphere of the SF-12 scale in the resurfacing arthroplasty group. CONCLUSIONS Resurfacing hip arthroplasty increased oxidative stress, increased the concentration of metal ions, and did not affect alignment of the abbreviation of the operated limb. A significant improvement in the quality of life of patients in the mental sphere according to the SF-12 occurred after the application of resurfacing arthroplasty, in the first month after the procedure.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35831982 PMCID: PMC9295415 DOI: 10.12659/MSM.936335
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Demographic data of the studied group of patients (data presented as means±SD or in%).
| Parameter | Femoral neck arthroplasty group (n=21) | Resurface arthroplasty group (n=21) |
|
|---|---|---|---|
| Body weight (kg) | 89.5±12.1 | 97.0±17.7 | 0.169 |
| Height (m) | 1.77±0.06 | 97.0±17.7 | 0.254 |
| BMI (kg/m2) | 28.6±3.55 | 30.2±5.27 | 0.325 |
| Ischemic heart disease | 0% | 14% | 0.075 |
| Hypertension | 33% | 43% | 0.537 |
| Diabetes | 0% | 5% | 0.323 |
BMI – body mass index.
Clinical characteristics of the studied population of patients (data presented as means±SD).
| Parameter | Femoral neck arthroplasty group | Resurface arthroplasty group |
|
|---|---|---|---|
| Number of months after surgery | 34.0±15.3 | 58.9±7.25 |
|
| Age at the time of surgery (years) | 44.1±9.0 | 53.1±9.7 |
|
| Age at the time of inspection (years) | 46.9±9.42 | 58.6±9.79 |
|
| Head size diameter (mm) | 38.0±3.79 | 52.6±1.69 |
|
| Cup size diameter (mm) | 55.2±2.79 | 58.6±1.69 |
|
| Local reaction (pseudotumor) | 0.0% | 0.0% | 1.000 |
Evaluation of parameters of oxidative stress in the studied groups of patients at individual stages of the study.
| Parameter | Femoral neck arthroplasty group | Resurface arthroplasty group |
|
|---|---|---|---|
|
| |||
| SH (μmol/L) – serum | 242±45.2 | 182±47.4 |
|
| CER (mg/dL) – serum | 39.3±7.09 | 35.4±6.28 | 0.073 |
| TAC (mmol/L) – serum | 0.97±0.22 | 0.91±0.10 | 0.274 |
| TOS μmol/L | 9.02±2.91 | 11.13±3.37 |
|
| LPH (μmol/L) – serum | 4.97±2.01 | 6.52±1.74 |
|
| SOD (NU/mL) – serum | 19.5±3.35 | 17.3±1.84 |
|
| LPS (RF) – serum | 887±230 | 868±240 | 0.795 |
| MDA (μmol/L) – serum | 2.30±0.93 | 2.26±0.51 | 0.867 |
| GR (IU/g Hb) – erythrocytes | 7.99±1.64 | 6.23±1.53 |
|
| CAT (kU/g Hb) – erythrocytes | 473±125.7 | 588±65.3 |
|
| SOD (NU/mgHb) – erythrocytes | 164±31.7 | 172±27.96 | 0.415 |
| GPX (IU/gHb) – erythrocytes | 59.2±12.31 | 44.7±4.61 |
|
| GST (IU/gHb) – erythrocytes | 0.15±0.04 | 0.19±0.08 |
|
| LPS (RF/gHb) – erythrocytes | 816±381 | 1572±512 |
|
| MDA (μmol/gHb) – erythrocytes | 0.41±0.08 | 0.41±0.04 | 0.957 |
|
| |||
| SH (μmol/L) – serum | 273±71.3 | 235±49.2 |
|
| CER (mg/dL) – serum | 27.7±10.19 | 38.9±8.71 |
|
| TAC (mmol/L) – serum | 1.07±0.16 | 1.06±0.11 | 0.742 |
| TOS μmol/L | 5.83±2.44 | 7.60±2.57 |
|
| LPH (μmol/L) – serum | 2.63±1.31 | 3.19±1.48 | 0.204 |
| SOD (NU/mL) – serum | 18.6±4.28 | 18.8±1.94 | 0.817 |
| LPS (RF) – serum | 445±332 | 856±205 |
|
| MDA (μmol/L) – serum | 3.30±1.39 | 2.81±1.02 | 0.197 |
| GR (IU/g Hb) – erythrocytes | 7.96±1.55 | 8.70±1.38 | 0.108 |
| CAT (kU/gHb) – erythrocytes | 490±89.8 | 577±55.7 |
|
| SOD (NU/mgHb) – erythrocytes | 151±16.4 | 162±20.93 | 0.054 |
| GPX (IU/gHb) – erythrocytes | 67.6±9.03 | 56.5±5.56 |
|
| GST (IU/gHb) – erythrocytes | 0.19±0.04 | 0.19±0.07 | 0.844 |
| LPS (RF/gHb) – erythrocytes | 867±327 | 1994±382 |
|
| MDA (μmol/gHb) – erythrocytes | 0.29±0.08 | 0.42±0.05 |
|
CAT – catalase; Cer – ceruloplasmin; GR – glutathione reductase; GPX – glutathione peroxidase; GST – glutathione S-transferase; LPH – lipid hydroperoxides; LPS – lipofuscin; MDA – malondialdehyde; SH – sulfhydryl; SOD – superoxide dismutase; TAC – total antioxidant capacity; TOS – total oxidant status.
Assessment of concentrations of tested metal ions in the studied groups of patients at particular stages of the study (data presented as mean±SD).
| Parameter | Femoral neck arthroplasty group | Resurface arthroplasty group |
|
|---|---|---|---|
|
| |||
| Cr concentration (μg/L) | 1.25±1.53 | 4.11±8.87 |
|
| Co concentration (μg/L) | 0.98±1.05 | 2.96±3.39 |
|
| Ni concentration (μg/L) | 0.89±0.56 | 0.91±0.10 |
|
|
| |||
| Cr concentration (μg/L) | 1.40±2.75 | 4.84±8.14 |
|
| Co concentration (μg/L) | 1.19±1.77 | 2.94±4.76 |
|
| Ni concentration (μg/L) | 0.89±0.54 | 1.23±0.36 | 0.897 |
Co – cobalt; Cr – chromium; Ni – nickel.